التفاصيل البيبلوغرافية
العنوان:
Efficacy and safety of a fixed combination of insulin degludec/insulin aspart in children and adolescents with type 1 diabetes: A randomized trial
المؤلفون:
Ona Kinduryte , Larry C. Deeb , Tadej Battelino , Georgeanna J. Klingensmith , Margarita Kovarenko , Naim Shehadeh , Mirjana Kocova , Magnus Ekelund
المصدر:
Pediatric Diabetes . 19:1263-1270
بيانات النشر:
Hindawi Limited, 2018.
سنة النشر:
2018
مصطلحات موضوعية:
Male , Insulin degludec , medicine.medical_specialty , Adolescent , Endocrinology, Diabetes and Metabolism , 030209 endocrinology & metabolism , 030204 cardiovascular system & hematology , Hypoglycemia , Gastroenterology , law.invention , Insulin aspart , 03 medical and health sciences , 0302 clinical medicine , Randomized controlled trial , law , Internal medicine , Post-hoc analysis , Internal Medicine , medicine , Humans , Hypoglycemic Agents , Child , Adverse effect , Type 1 diabetes , business.industry , Infant , Ketosis , medicine.disease , Insulin, Long-Acting , Drug Combinations , Diabetes Mellitus, Type 1 , Basal (medicine) , Child, Preschool , Pediatrics, Perinatology and Child Health , Female , business , medicine.drug
الوصف:
BACKGROUND Insulin degludec/insulin aspart (IDegAsp) is a fixed soluble co-formulation of basal and bolus insulin. OBJECTIVE To evaluate efficacy and safety of IDegAsp in pediatric patients with type 1 diabetes (T1D). SUBJECTS Children and adolescents (aged 1 to
تدمد:
1399-543X
الوصول الحر:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8686212bb2fd9bf90f9ad758c3e7e9f4Test https://doi.org/10.1111/pedi.12724Test
حقوق:
OPEN
رقم الانضمام:
edsair.doi.dedup.....8686212bb2fd9bf90f9ad758c3e7e9f4
قاعدة البيانات:
OpenAIRE
